Dingkang

Chime Biologics, widely known in China as Dingkang, is a leading Contract Development and Manufacturing Organization (CDMO) providing comprehensive biologics manufacturing services. Headquartered in Wuhan, the company operates a state-of-the-art facility featuring the world's first KUBio modular biomanufacturing platform, which utilizes single-use technology to ensure high-quality and flexible production. Chime Biologics offers end-to-end solutions from cell line development to large-scale commercial supply, specializing in monoclonal antibodies, bispecifics, and recombinant proteins. The company was established through the restructuring of JHL Biotech's assets and has since expanded its capabilities to include advanced modalities such as viral vectors and mRNA.